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Abstract. VAMP/synaptobrevin is part of the synaptic 
vesicle docking and fusion complex and plays a central 
role in neuroexocytosis. Two VAMP (vesicle-associ- 
ated membrane protein) isoforms are expressed in the 
nervous system and are differently distributed among 
the specialized parts of the tissue. Here, VAMP-1 and 
-2 are shown to be present in all rat tissues tested, in- 
cluding kidney, adrenal gland, liver, pancreas, thyroid, 
heart, and smooth muscle. The two isoforms are differ- 
entially expressed in various tissues and their level may 
depend on differentiation. VAMP-1 is restricted to exo- 
crine pancreas and to kidney tubular cells, whereas 
VAMP-2 is the predominant isoform present in 
Langerhans islets and in glomerular cells. Both iso- 
forms show a patchy vesicular intracellular distribution 
in confocal microscopy. The present results provide ev- 
idence for the importance of neuronal VAMP proteins 
in the physiology of all cells. 
UKARYOTIC cells possess organized secretory path- 
ways for the exocytosis of proteins and other mole- 
cules. These secretory routes consist of several dis- 
crete membrane compartments and of transport vesicles 
that shuttle between these compartments (Rothman and 
Orci,  1992; Pryer et al.,  1992; Simons and Zerial,  1993; 
Bennett and Scheller, 1993; Rothman and Warren, 1994). 
Membrane fusion of carrier vesicles may be constitutive 
(i.e., vesicle budding from the endoplasmic reticulum and 
fusing with the Golgi), or regulated (i.e., synaptic trans- 
mission). Though exocytosis takes place in virtually every 
cell  (Burgoyne  and  Morgan,  1993),  certain  tissues  are 
highly specialized in such a function and nerve cells pos- 
sess the most sophisticated and tightly controlled secretory 
apparatus (Kelly, 1993a). 
Presynaptic nerve terminals are filled with small synap- 
tic vesicles (SSV) 1, which contain chemical neurotransmit- 
ters, and with the less abundant larger dense-core vesicles 
loaded with neuropeptides. Most SSVs are attached to the 
cytoskeleton via  the  synapsins and  constitute  a  reserve 
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1. Abbreviations used in this paper: VAMP, vesicle-associated membrane 
protein; NSF, N-ethyl-maleimide sensitive factor; SNAP, soluble NSF at- 
tachment protein; SNAP-25, synaptosomal-associated protein of 25 kD; 
SSV, small synaptic vesicles; TENT, tetanus neurotoxin; NRK, normal rat 
kidney cells;  PC12,  rat  pheochromocytoma cells;  RIN,  rat  insulinoma 
cells. 
neurotransmitter pool (Hirokawa et al., 1989; Valtorta et 
al., 1992; Greengard et al., 1993; De Camilli, 1995). A small 
percentage of SSVs is bound to active zones of the presyn- 
aptic membrane, ready to discharge their content in the in- 
tersynaptic space. Neuroexocytosis is triggered by a local 
increase in calcium concentration consequent to opening 
of voltage-gated calcium channels by membrane depolar- 
ization. The SSV membrane fuses very rapidly (200-300 
txsec)  with  the  presynaptic  membrane  (Almers,  1994). 
Fused SSVs  are then rapidly retrieved and recycled in a 
dynamin-dependent process  (Heuser  and  Reese,  1973; 
Bennett and Scheller, 1993, 1994; Takei et al.,  1995; Stid- 
hof, 1995). 
The abundance of SSVs in brain and the availability of a 
well defined and efficient protocol of isolation has lead to 
the molecular characterization of many SSV protein com- 
ponents (Hiittner et al., 1983; Bennett and Scheller, 1993, 
1994; Stidhof, 1995). Apart from proteins involved in the 
uptake of neurotransmitters (Schuldiner et al., 1995), very 
little is known about the function of these proteins. S611ner 
et al. (1993a,b)  have identified a 20-S multi-subunit com- 
plex likely to be responsible for vesicle docking and fusion 
in  the  cell. This  complex includes the  vesicular protein 
VAMP (vesicle-associated membrane protein; also known 
as synaptobrevin), the presynaptic membrane-bound pro- 
teins SNAP-25 (synaptosomal-associated protein of 25 kD), 
syntaxin and soluble factors which include NSF (N-ethyl- 
maleimide sensitive factor), et/~ and ~/SNAPs (Malhotra et 
al., 1988; Trimble et al., 1988; Oyler et al., 1989; Clary et 
al., 1990; Bennett et al., 1992). Each of these proteins has a 
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brane fusion apparatus  is  conserved from yeast to man 
(Pryer et al., 1992; Ferro-Novick and Jahn, 1994; Stidhof, 
1995). 
VAMP, a  major component of the SSV membrane, is 
clearly implicated in neuroexocytosis since it is the specific 
target  of the  zinc-endopeptidase activity of tetanus  and 
botulinum B, D, F, and G neurotoxins, which cause a sus- 
tained inhibition of neurotransmitter release (Schiavo et 
al.,  1992a, b;  1993a,  b,c;  1994;  Yamasaki  et  al.,  1994). 
VAMP was first identified by screening a cDNA library of 
the Torpedo electric organ (Trimble et al., 1988) and later 
cloned from rat, bovine, human, Drosophila, yeast, squid, 
and Aplysia (Elferink et al., 1989; S0dhof et al., 1989; Ar- 
cher et al., 1990; Chin et al., 1993; Di Antonio et al., 1993; 
Protopopov et al., 1993; Hunt et al., 1994; Yamasaki et al., 
1994; Sweeney et al., 1995). Four regions can be identified 
in  the  primary structure  of VAMP.  An  amino-terminal 
part is very rich in prolines and is not conserved among 
species and isoforms both in terms of sequence and length. 
A  central hydrophilic and charged domain is highly con- 
served and contains the sites of cleavage of clostridial neu- 
rotoxins. A  third transmembrane region is followed by a 
short carboxyl terminal hydrophilic sequence of variable 
length in the different species. Proteolysis, antibody bind- 
ing, and the knowledge that clostridial neurotoxins oper- 
ate in the cytosol (Trimble et al., 1988; Stidhof et al., 1989; 
Montecucco and Schiavo, 1993) indicate that VAMP is a 
type II protein with a cytosolic amino terminus and a mem- 
brane-anchoring carboxyl end (Kutay et al., 1993, 1995). 
Two isoforms of VAMP were identified in the nervous 
and neuro-endocrine tissues with dissimilar amino-termi- 
nal proline-rich domain part  (Baumert et al.,  1989;  Elf- 
erink et al., 1989; Archer et al., 1990; Chin et al., 1993). In 
situ hybridization shows that they are differently distrib- 
uted among the various brain regions (Trimble et al., 1991; 
Chin et al.,  1993).  More recently, a third VAMP isoform 
with a shorter amino terminal, termed cellubrevin, has been 
characterized by McMahon et al.  (1993). Cellubrevin was 
suggested  to  be  a  nonneuronal  member  of the  VAMP 
family mainly associated to endosomes. 
Using polyclonal antisera raised vs rat brain VAMPs, 
glucose transporter-containing vesicles, isolated from adi- 
pose tissue, were shown to contain a doublet of VAMPs 
(Corley-Cain et al., 1992). Moreover, in situ hybridization 
shows the presence of VAMP in Malpighian tubes and in 
the gastro-intestinal epithelia of Drosophila melanogaster 
(Chin et al.,  1993).  More recently, VAMPs were also de- 
tected in  skeletal  muscle  and  pancreas  (Ralston  et  al., 
1994; Braun et al., 1994; Gaisano et al., 1994; Regazzi et 
al.,  1995).  Finally, tetanus neurotoxin, which specifically 
cleaves VAMP, inhibits the exocytosis of lysozyme in mac- 
rophages (Pitzurra et al.,  1989).  Taken together these re- 
suits  indicate  that  neuronal  VAMP  isoforms or related 
proteins  may  be  expressed  outside  the  nervous  tissue. 
Here, we document the distribution of neuronal VAMP-1 
and  -2  isotypes outside  the  nervous tissue  with  various 
techniques. We show that the two isoforms are differen- 
tially expressed in different tissues. These results suggest 
that  these proteins  play  an  active role  in  exocytosis in 
many cell types and that the two isoforms have specialized 
functions. 
Materials and Methods 
Probes Used 
Rat VAMP-1 and -2 eDNA clones corresponding to full-length mRNA 
were described previously (Elferink et al., 1989). 
Northern Blotting and RNase Protection Assay 
Total RNA was extracted from adult rat tissues using the procedure de- 
scribed by Chomczynski and Sacchi (1987). RNA concentration was de- 
termined by O.D. measurement and ethidium bromide staining of formal- 
dehyde agarose gel electrophoresis. 
For Northern blot, 30 ~g from each tissue was size fractionated on a 
1% agarose gel containing 2.2 M formaldehyde and transferred to nylon 
filter by capillary elution. (Sambrook et al., 1989) Blotted RNA was fixed 
following manufacturer's instructions and hybridized overnight at 52°C 
with 5  ×  106 full-length VAMP-1 and -2 probes, labeled with 32p-dATP 
with Klenow DNA polymerase. The final washings were performed in 0.5 
×  SSC (IX SSC: 0.15 M NaC1, 0.015 M sodium citrate, pH 7.6), 0.1% SDS 
at 65°C. Filters were exposed to x-ray film for 15 d. 
For RNase protection assay antisense cRNA probes corresponded to 
the 3'UTR of each mRNA: VAMP-1 probe was 330 nt in length and was 
transcribed from VAMP-1 eDNA after digestion at the XbaI site; VAMP-2 
probe was 415 nt in length and was transcribed from VAMP-2 eDNA after 
digestion at the BamHI site. Nucleotide sequence analysis confirmed the 
existence of high divergence at this site between the two mRNAs. RNase 
protection assay was performed using RPA II kit (Ambion, Austin, TX). 5 
Ixg of total RNA from adult rat brain and spinal cord, 50 p~g from kidney, 
adrenal gland, heart atrium, ventricle, and liver were hybridized overnight 
at 45°C in 80% formamide, 100 mM Na citrate, 300 mM Na acetate, pH 
6.4,  1 mM EDTA with 105 cpm of gel purified 32p-labeled VAMP-1 or 
VAMP-2 antisense probe. 1 p~g of total RNA from each sample was hy- 
bridized with 6 ×  104 cpm of mouse 13 actin cRNA probe as a control. Af- 
ter digestion with RNases A  and T1, samples were separated by electro- 
phoresis with  5%  denaturing polyacrylamide gel.  Molecular weight of 
protected fragments was determined using 100 bp DNA ladder (Pharma- 
cia LKB Biotechnology, Piscataway, NJ) labeled with 32p-dCI'P with Kle- 
now  DNA  polymerase.  Autoradiography was  developed  after  4  d  at 
-80°C. 
In Situ Hybridization 
Adult male Wistar rats (200-250 gr) were anesthetized with sodium pen- 
tobarbital (50 mg/ml) and perfused trans-cardiacally  with isotonic saline 
buffer, followed by 4% paraformaldehyde in PBS. The organs O  f interest 
were removed, postfLxed for 3 h in the perfusion buffer, and cryoprotected 
by immersion in a series of cold, graded sucrose solution in isotonic saline 
buffer to a final concentration of 18%. The organs were frozen with dry 
ice and cut into 8-p,m-thick sections with microtome and mounted onto 
chrome potassium/gelatin slides. Prehybridization treatments and hybrid- 
ization conditions were essentially as described by Gorza et al. (1993).  An- 
tisense and sense [35S-RNA]  transcripts corresponding to the full-length 
VAMP-1 and VAMP-2 mRNAs were synthesized using T3 or T7 RNA 
polymerase (Boehringer-Mannheim) to a  specific radioactivity of 1.2  × 
108 cpm/p.g after linearization of VAMP-I and VAMP-2 eDNA clones. 
Radiolabeled sense and antisense cRNA were digested by mild alkali hy- 
drolysis to 100 nt fragments. Before hybridization, sections were digested 
with Proteinase K (Boehringer Mannheim Corp., Indianapolis, IN) 20 txg/ 
ml in 10 mM TrisHCl, 5 mM EDTA, pH 7.8 at room temperature for 7.5 
min. Hybridization was carried on using 105 cpm of 35S-labeled  probe in 
50%  formamide, 20 mM Tris-HC1, 0.3 M  NaC1,  5 mM EDTA, 10 mM 
NaH2PO4, 10% dextran sulfate, 1× Denhardt's solution, 10 mM DTT and 
0.1 mg/ml of denaturated yeast tRNA and incubating overnight at 52°C. 
The highest stringency wash was performed in 50% formamide 2× SSC, 
10 mM DTI" for 20 rain at 65°C and was followed by digestion with 20 p~g/ 
ml RNase A in 10 mM TrisHCl, 0.4 M NaC1, 5 mM EDTA pH 7.5 for 30 
rain at 37°C.  After air drying, sections were placed in film cartridges and 
exposed to Kodak x-Omat film for 1-3 d. Slides prepared for autoradiog- 
raphy were coated with NTB-2 emulsion (diluted 1:2 with water), exposed 
at 4°C and developed with Kodak D-19 developer. In each experiment, 
pairs of slides hybridized with sense and antisense cRNAs were developed 
after 2 and 7 d of exposure. Some slides were counterstained with hema- 
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contrast optics was used for examination. 
Antibody Production 
Synthetic NH2-terminal 1-33 peptides of rat VAMP-1 and VAMP-2 were 
synthesized using an automated solid-phase peptide synthesizer with Fast- 
Moc chemistry (Applied Biosystems,  Foster City, CA). The two peptides 
were purified by HPLC using a reverse phase C8 Ultra-Sphere preparative 
column (Beckman Intrs., Fullerton, CA), conjugated to keyhole limpet 
hemocyanin (Pierce, Rockford, IL) and mixed with Freund's adjuvant and 
3 mg of heat-killed Mycobacterium tuberculosis (Difco, Detroit, MI). New 
Zealand white rabbits were immunized subcutaneously followed by intra- 
muscular injections 3 wk apart (Vaitukaitis, 1981). Serum was affinity pu- 
rified by binding to,  and eluting from, the peptide bound to  an AH- 
Sepharose 4B matrix (Pharmacia). These affinity purified antibodies rec- 
ognize  the  bands  of  the  correct  size  corresponding to  VAMP-1  and 
VAMP-2,  respectively,  both  in  recombinant full-length VAMP-1  and 
VAMP-2 GSH fusion protein (Fig. 5), and in purified rat brain small syn- 
aptic vesicles (not shown) run in high resolution SDS-PAGE gels (Htitt- 
ner et al., 1983; Schiavo et al., 1992b). 
Tissue Sample Preparation and Western Blot 
Organs were isolated from adult rats and homogenated in homogenation 
buffer containing 50 mM Tris-HCl, 2% SDS, 0.5 mM EDTA, 0.4 mM ben- 
zamidine, 0.1  mM N-p-tosyl-L-lysinechloromethyl ketone  (TLCK),  0.1 
mM N-tosyl-L-phenylalanin chloromethyl ketone (TPCK) 2 p~g/ml pep- 
statin A and 0.2 mM PMSF, (Sigma Chem.Co.,  St. Louis, MO) pH 7.0, and 
centrifuged for 5 rain at 15,000 rpm. Supernatants were precipitated with 
trichloracetic acid in order to eliminate DNA, centrifuged for 10 s and pel- 
lets were resuspended in homogenation buffer without protease inhibi- 
tors. Protein concentration was  determined with the method of Lowry 
(Markwell et al., 1981) using bovine serum albumin (BSA) as a standard. 
Tissue protein samples (175 ~g/lane) were loaded onto a 13-18% SDS- 
polyacrylamide linear gradient gel (Laemmli, 1970) transferred to nitro- 
cellulose (Schleicher and Schuell, Keene, NH) for 3 h at 400 mA (Towbin 
et al.,  1979).  Stripes were probed with affinity purified antibody anti- 
VAMP-1 and anti-VAMP-2 (1:200 dilution, 16 h at 4°C) and stained with 
goat  anti-rabbit IgG  conjugated to  alkaline  phosphatase  (Boehringer 
Mannheim Corp.) (1:10,000 dilution, 2 h at 20°C). 
Cell Cultures 
The PC12  subclone used here was kindly provided by Dr. T. R. Rogers 
(University of Maryland School of Medicine). PC12 were cultured at 37°C 
on plastic dishes (100 mm diam) coated with collagen as described by Wal- 
ton et al. (1988) and grown in DMEM (Flow, U. K, supplemented with 44 
mM sodium bicarbonate), 7.5% horse serum, 7.5% FCS, pH 7.4 in a hu- 
mid atmosphere of 5% CO2 in air. NRK and RIN were cultured at 37°C 
on plastic dishes (100 mm diameter) in DMEM and RPMI, respectively, 
supplemented with 10% FCS, 100 U/ml penicillin and 100 p~g/ml strepto- 
mycin.  Weekly subcultivations were performed at initial cell density of 
0.5-1  x  106 cells per 100-mm diameter dish. Immunofluorescence experi- 
ments were performed on ceils seeded on coverslips (10-50 × 104 cells/well 
in 12 well plates) coated with poly-lysine. 
Immunofluorescence Microscopy 
Cells. All procedures were carried out at room temperature. After three 
washings in PBS, cells were fixed in 4% paraformaldehyde in PBS for 20 
min, rinsed once with PBS and twice for 10 min in PBS containing 0.38% 
glycine and 0.27%  NI-LC1. After three PBS washes, cells were permeabi- 
lized, in PBS containing 0,5 % BSA, 0.1% saponin for 30 min (blocking so- 
lution). Ceils were incubated with affinity purified antibody anti-VAMP-1 
or VAMP-2 diluted 1:200 in blocking solution for 1 h. After five washes 
with blocking solution, they were incubated with fiuorescein-conjugated 
pig anti-rabbit IgG secondary antibody (DAKO) diluted 1:100 in block- 
ing solution for 30 rain.  For double staining, the primary step was with 
mouse anti-synaptophysin (Boehringer-Mannheim), in combination with 
rabbit anti-VAMP-1 or anti-VAMP-2. This was followed by FITC-conju- 
gated pig anti-rabbit IgG in combination with Texas red-coupled horse 
anti-mouse immunoglobulins (Vector Labs, Burlingame, CA). Cells were 
washed five times with blocking solution and mounted in 90% glycerol- 
PBS containing 3 % N-propylgallate. Specimens were observed using a Ni- 
kon RCM 8000 confocal microscope. 
Cryosections. Prefixed  cryosections of rat  pancreas,  kidney,  adrenal 
gland and liver were incubated at room temperature for 3 h with affinity 
purified anti-VAMP-1 or -2 diluted 1:200 in PBS containing 3% BSA. Af- 
ter three washings  in PBS,  they were incubated with rhodamine-conju- 
gated pig anti-rabbit IgG secondary antibodies (DAKO) diluted 1:200 in 
PBS-3% BSA. Slides were washed three times in PBS, mounted in Mow- 
iol (Sigma), and observed under a light microscope. 
Results 
Expression in Different Tissues of VAMP-1 
and -2 mRNAs 
Previous  studies  on  the  distribution  of  VAMPs  among 
species and  tissues  have suggested that VAMP isoforms 
are involved in cellular functions specific for nervous and 
neuro-endocrine  tissues.  The  identification  in  nonneu- 
tonal  cells of cellubrevin, an isoform with  a  distinct  pri- 
mary structure,  is also in keeping with a  tissue restricted 
distribution of VAMPs. However, a  scattered set of data 
indicated the presence of VAMPs in other tissues. 
Preliminary Northern blotting experiments with mRNA 
extracted from different tissues and hybridized with 32p_ 
labeled eDNA probes showed that  the  rat brain VAMP 
isoforms mRNAs were expressed in  all nonneuronal  tis- 
sues tested (data not shown). To exclude cross-reactivity 
due to high homology between coding regions of VAMP-1 
and VAMP-2 mRNAs and to increase signals, RNase pro- 
tection assay was performed using antisense cRNAs corre- 
sponding to the 3' untranslated  region as a  probe. Fig.  1 
reports the result of such an assay performed on rat brain, 
spinal cord, kidney, adrenal gland, heart atrium, and ven- 
tricle and liver. VAMP-1  and -2 mRNAs protected frag- 
ments have the same size in all tissues tested and in brain 
Figure 1.  RNase protection assay of VAMP-1 (A) and VAMP-2 
(B) mRNAs in rat tissues. 50 p,g of yeast tRNA was used as nega- 
tive control (lane 1); lanes 2 and 3 were loaded with 5 I~g of total 
RNA from brain (2) and spinal cord (3); lanes 4-8 were loaded 
with 50  p,g  of kidney  (4),  adrenal  gland  (5),  heart  atrium  (6), 
heart ventricle (7), and liver (8). Hybridization results in a  pro- 
tected fragment of about 280 nt for VAMP-1 (A) and a fragment 
of about 350 nt for VAMP-2 (B). 
Rossetto et al. Tissue Distribution of VAMP/Synaptobrevin  169 Figure 2. In situ hybridization of kidney with antisense and sense VAMP-1 and -2 cRNA probes: phase contrast (A and D) and dark- 
field microphotographs (B, C, E, and F) of in situ hybridization with antisense [35S-cRNA] probes of VAMP-1 (A and B) and VAMP-2 (D 
and E) and with sense [35S-cRNA]  probes of VAMP-1 (C) and VAMP-2 (F) of kidney. G, glomerula. Bar, 50 Ixm. 
and spinal cord, indicating that the same neuronal mRNA 
species are expressed outside the nervous tissue. This con~ 
clusion is also based on the fact that there are no intrones 
in the rat VAMP genes (Elferink et al., 1989). 
! 
A relative Comparison of the level of the signal given by 
the  various  nonneuronal  tissues  with  respect  to  that  of 
brain indicates that, in general, VAMP-2 mRNA signal is 
higher than that of VAMP-l, except for heart. The marked 
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isoform 2 in the spinal cord with respect to brain is note- 
worthy. The level of expression of the  two VAMP iso- 
forms found  here  appears  to  correlate with  the  known 
secretory activity of kidney, liver, and adrenal glands. The 
large amount of VAMPs in the heart was unexpected and 
its significance remains to be explained. 
To obtain  information on  the  distribution  of the  two 
VAMP mRNA isoforms within the different parts of a tis- 
sue,  an in  situ  hybridization study with  [35S]RNA  sense 
and antisense probes spanning the entire coding region of 
the two rat brain VAMP isoforms was performed. Figs. 2, 
3, and 4 show the distribution of VAMP-1 and -2 mRNAs 
in kidney, in pancreas and in thyroid, liver, adrenal gland 
and aorta, respectively. Both antisense probes show strong 
hybridization  signals  with  neuronal  cells  (not  shown) 
whereas no signal is observed with the sense probes (Fig. 
2, C and F). In the kidney, isoform 1 shows a uniform dis- 
tribution (Fig. 2, A  and B), but hybridization signals  are 
much  weaker  than  those  observed  in  the  brain.  Con- 
versely,  strong  hybridization  signals  are  observed  for 
VAMP-2  mRNA  in  both  tubular  and  glomerular  cells 
(Fig. 2, D  and E). In pancreas there is a clear differential 
distribution  of the  two  isoforms:  VAMP-1  mRNA  pre- 
dominates in the exocrine acinar cells (Fig. 3, A  and B), 
whereas  VAMP-2  mRNA  is  enriched  in  the  endocrine 
Langerhans islets (Fig. 3, C and D). It is noteworthy that 
the arterial wall contains VAMP-2, but appears to be de, 
void of VAMP-1 mRNA. 
Fig. 4 shows the distribution of the mRNAs of VAMP-1 
and -2 in thyroid, liver, adrenal gland, and aorta. The two 
isoform mRNAs are present at the same level in thyroid 
and are localized mainly in the follicular cells (panels A 
and E). In liver, the signal for VAMP-1 is lower than that 
of VAMP-2 in agreement with the RNase protection assay 
(panels B and F). VAMP-2 appears to be expressed at dif- 
ferent  levels  in  different  liver  cell  types.  Hematoxylin 
staining of VAMP-2 prehybridized slides identifies hepa- 
tocytes as VAMP-2 mRNA expressing liver cells, whereas 
Kupffer cells display only background levels of hybridiza- 
tion (not shown). VAMP-1 mRNA is enriched in the me- 
dulla of the adrenal gland. In contrast, VAMP-2 mRNA is 
higher in the cortical than in the medullar portion (Fig. 4, 
C and G). Fig. 4 also shows that VAMP-2 mRNA is clearly 
present in  the  smooth  muscle cells of aorta,  in  a  larger 
amount with respect to VAMP-1 mRNA (panels D and H). 
Figure 3. In situ hybridization of pancreas with antisense VAMP-1 and -2 cRNA probes. Phase contrast (A and C) and dark-field (B and 
35  D) microphotographs of in situ hybridization with antisense [  S-cRNA] probes of VAMP-1 (A and B) and VAMP-2 (C and D) of pan- 
creas. A, artery; L, islet of Langerhans. Bar, 50 I~m. 
Rossetto  et al. Tissue Distribution of VAMP/Synaptobrevin  171 Figure 4. In situ hybridization of thyroid, liver adrenal gland and aorta with antisense VAMP-1 and -2 cRNA probes. Dark-field micro- 
photographs  of in situ hybridization with antisense [35S-cRNA] probes of VAMP-1 (A-D) and VAMP-2 (E-H) of thyroid (A and E), 
liver (B and F) adrenal gland (C and G) and aorta (D and H). F, folliculum; CV, central vein; T, Glisson trias; M, medulla; C, cortex; L, 
lumen;/, intima; MD, media; A, adventitia. Bars: (A, B, D, E, F, and H) 50 p~m; (C and G) 150 Ixm. 
VAMP Proteins Are Present in Different Amounts in 
Nonneuronal Tissues 
The presence and tissue distribution of the two "neuronal" 
VAMP isoforms was assayed with antibodies raised in rab- 
bits against the 1-33 amino-terminal part of VAMP. This 
part of the VAMP molecule is not conserved among spe- 
cies and isoforms. After affinity purification on antigen- 
bound columns, these antibodies showed no cross-reaction 
among  recombinant  full-length  rat  brain  VAMP-1  and 
VAMP-2  produced  as  fusion  protein  with  glutathione 
S-methyltransferase (Fig. 5, A  and B). Alternatively, iso- 
form specificity was probed in Western blots on small synap- 
tic vesicles, isolated from rat brain cortex (Htittner et al., 
1983), where the two VAMP isoforms were differentiated on 
the basis of their slightly different electrophoretic mobility 
(not shown). These anti-VAMP-1 and VAMP-2 antibod- 
ies do not recognize eellubrevin because they do not stain 
protein bands of electrophoretic mobility higher than those 
of VAMP-1 and VAMP-2 in any of the tissues tested. 
Fig.  5  shows that these antibodies recognize rat brain 
VAMP isoforms in all the tissues tested. From their elec- 
trophoretic mobility, it appears that the VAMP proteins of 
the various tissues have very similar sizes, close or identi- 
cal to that of neuronal VAMPs. Slight differences in elec- 
trophoretic mobility between the brain VAMPs  and the 
other tissue VAMP bands is most likely due to the higher 
and different lipid content of brain, which includes gangli- 
osides and cerebrosides. This result is  in full agreement 
with the recent cloning and sequencing of the rat pancreas 
VAMP-2 gene (Regazzi et al., 1995), which was found to 
be identical to the neuronal one (Elferink et al., 1989). The 
amount of VAMP-1 and -2 isotypes in the various tissues, 
as judged from the intensity of immunostaining, correlates 
with the level of expression of their respective mRNAs, re- 
ported in Fig. 1. 
Immunofluorescence Analysis of the Distribution of 
VAMP Proteins in Different Tissues 
The distribution of VAMP-1  and -2 proteins within each 
tissue was studied by immunofluorescence of cryosections 
with  isoform  specific  antibodies.  Fig.  6  A  shows  that 
VAMP-1 is present in the exocrine cells of pancreas and is 
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hand, VAMP-2 is present both in endocrine and exocrine 
pancreas, but is predominant in the Langerhans islets of 
adult rat pancreas (Fig. 6 B). This latter result correlates 
with the presence of VAMP on zymogen granules of exo- 
crine pancreas (Braun et al.,  1994;  Gaisano et al.,  1994). 
Moreover,  it  is  fully consistent  with  the  fact  that  only 
VAMP-2  and  cellubrevin, but not  VAMP-1  genes were 
identified  in  a  pancreatic  [3-cell derived c-DNA  library 
(Regazzi et al., 1995).  The differential distribution of the 
two neuronal VAMP isoforms is much more evident than 
that assumed from the in situ hybridization experiments of 
Fig. 3. In kidney, VAMP-1  stains the tubular cells and is 
absent from glomeruli, while VAMP-2 is present in both 
tubular and glomerular cells (Fig. 6, C and D). Panel F of 
Fig. 6 shows that VAMP-2 is concentrated in the medullar 
part of the adrenal gland, whereas VAMP-1  stains more 
the cortical than the medullar portion. When preimmune 
antisera were used there was no fluorescent staining. This 
is also the case when VAMP-1  or VAMP-2 amino-termi- 
nal peptides were used as competition to the purified anti- 
bodies. In pancreas, kidney, and adrenal gland there ap- 
pears  to  be  no  close  correlation  between  the  level  of 
VAMP-1  and  -2  mRNA  and  protein expression. This is 
not unprecedented since it has been detected before for 
different mRNA species (Gorza et al.,  1993; Moschella et 
al., 1995; Kelly et al., 1995). Such discrepancies may be ac- 
counted  for by a  different stability  of VAMP-1  and  -2 
mRNA and/or proteins in different cell types. Moreover 
partial cross-hybridization of the full-length cRNA probes 
and different posttranslational regulation of the two VAMP 
isoform mRNAs may also be involved. 
IntraceUular Distribution of VAMP-1 and -2 
The intracellular distribution of neuronal VAMP proteins 
was studied by confocal immunofluorescence microscopy 
:on  rat  insulinoma  cells  (RIN),  rat  normal  kidney  cells 
(NRK),  and  rat  pheochromocytoma cells  (PC12).  Cells 
were fixed, permeabilized, and stained with affinity puri- 
fied rabbit antibodies anti-VAMP-1 or anti-VAMP-2. Fig. 
7 shows that in RIN cells VAMP-2 staining has a spotty dis- 
tribution in the entire cytosol (b), whereas VAMP-1 is ab- 
sent (a) in agreement with the data obtained in pancreas. 
At variance, in NRK cells both VAMP isoforms are present 
and they show a vesicular-type staining (c and d). 
Fig. 8 shows that in undifferentiated PC12 cells, VAMP-1 
gives a fluorescent signal much lower than that of VAMP-2, 
whose amount differs in individual cells of the same cul- 
ture (b), though it shows in each cell a spotty distribution 
within the cytosol. Neuronal differentiation of these cells 
is  accompanied  by  a  large  increase  in  the  amount  of 
Rossetto et al. Tissue  Distribution of VAMP/Synaptobrevin  173 Figure 5. Western blot of recombinant GST-VAMP-1 and GST-VAMP-2 fusion proteins and tissue homogenates with affinity purified 
anti-VAMP-1  and anti-VAMP-2 polyclonal antibodies. Isoform specific polyclonal antibodies were raised in rabbits and purified by af- 
finity chromatography. The specificity of these two antibodies were tested by immunoblot of 5 ~g of recombinant GST-VAMP-1 and -2 
fusion proteins. Different tissue homogenates were treated as detailed in Materials and Methods, electrophoresed, blotted, and revealed 
with rabbit affinity purified anti-VAMP-1  (A) and anti-VAMP-2  (B) (brain, 1; kidney, 2; adrenal gland, 3; liver, 4; heart atrium, 5; heart 
ventricle, 6; pancreas, 7; thyroid, 8). The high amount of proteins loaded on the gel leads to a distortion of the VAMP bands and may 
slightly affect also electrophoretic mobility. 
VAMP-1 and in the appearance of intense staining of both 
VAMP-1  and -2 in synaptic terminals (panels c and d  of 
Fig. 8), identified by the presence of synaptophysin, a pro- 
tein specific of synaptic vesicles (panels e and fof Fig. 8). 
Discussion 
Docking  and  fusion  of vesicles  with  target  membranes 
within the cell is mediated by a set of proteins conserved 
from yeast to mammals (Rothman and Orci, 1992; Bennett 
and  Scheller,  1994;  Rothman  and  Warren,  1994;  Ferro- 
Novick and Jahn, 1994). On the basis of their topological 
localization, they can be divided into three groups: pro- 
teins located on the vesicle, proteins of the target mem- 
brane, and cytosolic proteins. These proteins form a multi- 
subunit complex of 20 S that assembles sequentially with a 
preliminary involvement of VAMP, syntaxin, and SNAP- 
25 (S611ner et al., 1993a, b; Rothman and Warren, 1994). Its 
synaptic vesicle location suggested that VAMP might play 
a major role in vesicle recognition of the target membrane 
via interactions with the presynaptic membrane proteins 
SNAP-25 and syntaxin. The identification of several syn- 
taxin isoforms and of the nonneuronal VAMP isoform cel- 
lubrevin lend support to this view. On this basis,  it was 
anticipated that vesicular trafficking among different in- 
traceUular compartments would be mediated by organelle 
and/or tissue specific isoforms (Bennett et al., 1993; Kelly, 
1993b;  S611ner et al., 1993b;  Warren, 1993; Rothman and 
Warren, 1994). 
So far three VAMP isoforms have been characterized in 
mammals:  two neuronal isoforms (VAMP-1  and -2) and 
one nonneuronal isoform (cellubrevin). Previous studies 
of distribution of VAMP-1  and -2 within the rat central 
nervous system with RNA probes showed that VAMP-1 
expression is mainly restricted to cells involved in somato- 
motor functions and to cells of the spinal  cord, whereas 
VAMP-2 is more widely expressed and present in nuclei 
associated with autonomic, sensory, and integrative roles 
(Elferink et al., 1989; Trimble et al., 1991). Another study 
employed an anti-VAMP monoclonal antibody and found 
VAMP in the nerve and neuro-endocrine cells, but not in 
other tissues (Baumert et al., 1989). This result is possibly 
due to a nonconservation of the epitope recognized by the 
monoclonal antibody used. Other studies have found that 
neuronal VAMP isoforms are expressed in the rat adipose 
tissue (Corley-Cain et al., 1992), in the gut and Malpighian 
tubules of D. rnelanogaster  (Chin et al., 1993) and in the 
exocrine pancreas (Braun et al., 1994). 
Here, the  presence  and  distribution  of both  neuronal 
VAMP isoforms among various rat tissues are clearly doc- 
umented with different experimental approaches.  These 
proteins are highly expressed in tissues with a high secre- 
tory activity such as thyroid and pancreas, and, in lower 
proportion, in all tissues tested including liver and smooth 
muscle cells. It was suggested that VAMPs are absent in 
chromaffin cells (Stecher et al.,  1989; Hrhne-Zehl et al., 
1993), but the results reported here demonstrate that they 
are indeed expressed in these cells. 
The Journal of Cell Biology, Volume 132, 1996  174 Figure 6. Light immunofluorescence microscopy of cryosections of rat pancreas, kidney, and adrenal gland with isoform specific VAMP 
antibodies: fluorescence images of cryosections of adult rat pancreas (A and B), kidney (C and D) and adrenal gland (E and F) stained 
with affinity purified anti-VAMP-1 (A, C, and E) or anti-VAMP-2 (B, D, and/7). L, islet of Langerhans; G, glomerula; M, medulla; C, 
cortex. Bar, 50 I~m. 
Rossetto et al. Tissue Distribution of VAMP/Synaptobrevin  175 Figure 7. Confocal immunofluorescence microscopy of RIN (a and b) and NRK (c and d) cell lines: stained with anti-VAMP-1  (a and c) 
and with anti-VAMP-2  (b and d). Bar, 5 I~m. 
There are clear differences in the distribution of the two 
neuronal VAMP isoforms among different areas of vari- 
ous tissues. The most striking case is that of pancreas, with 
VAMP-1  protein  present  in  the  exocrine  portions  and 
VAMP-2 being predominantly expressed in the endocrine 
parts. Though unexplained at the present time, these dif- 
ferences may reflect different functionalities of the exocy- 
totic complexes which include  the  different VAMP  iso- 
forms,  in  terms  of the  kinetics  of the  process,  calcium 
dependency, and molecules to be secreted. In this respect, 
it is noteworthy that only VAMP-2 appears to be present 
in the 20-S particle isolated from bovine brain in a system 
that secretes small molecules very rapidly (S611ner et al., 
1993a; Horikawa et al., 1993). We have recently found that 
only VAMP-2,  but not VAMP-l,  forms a  complex with 
synaptophysin and that this interaction is mediated by the 
amino-terminal domain (Washbourne et al., 1995). 
From the present results, it appears that the VAMP iso- 
forms detected in the various tissues are identical to the 
neuronal VAMP isoforms: (a) gene-specific probes at high 
stringency were used; (b) equal size of mRNA protected 
fragment were detected in the RNase digestion assay; (c) 
tissues were immunostained with affinity purified antibod- 
ies raised vs the only VAMP portion shown to vary among 
isoforms and species. This indicates that the amino-termi- 
nal part of the tissue VAMPs has to be closely similar to 
those of the neuronal isoforms; and (d) the electrophoretic 
mobility of the VAMPs is identical in nonneuronal tissue 
and the difference with brain is to be attributed to a lipid 
shift effect. The first cloning of a VAMP from a nonneu- 
ronal  tissue  (insulinoma cells)  has  shown  an identity to 
brain VAMP-2, extended to the noncoding flanking region 
of VAMP-2 (Regazzi et al., 1995). 
The limited repertoire of VAMP proteins, the apparent 
presence of only two isoforms in some secretory cells and 
the ubiquity of VAMP proteins with closely similar, if not 
identical, amino-terminal portions which is the VAMP re- 
gion expected to be associated with a specific recognition 
role, raise the possibility that VAMPs are not the only pro- 
teins  responsible  for targeting  of vesicle  to  the  plasma 
membrane. The apparent docking of SSV in synapses in- 
toxicated with tetanus  neurotoxin which cleaves specifi- 
cally VAMP (Mellanby et al., 1988; Neale, 1989; Hunt et 
al., 1994) can be attributed to vesicle recognition of active 
zones  of the  presynaptic membrane  mediated  by other 
proteins. Proteins that may be involved in docking small 
synaptic vesicles are synaptotagmin (S611ner et al., 1993b) 
and  the  cysteine string  proteins  (Zinsmaier et  al.,  1994; 
Mastrogiacomo et al.,  1994), shown to bind to the  Ca  2+ 
channels of the presynaptic membrane. Moreover, though 
small synaptic vesicles are one of the most characterized 
organelles, other vesicle proteins may be involved in target 
membrane recognition. Available evidence indicates that 
VAMP forms a hetero-trimeric complex with syntaxin and 
The Journal of Cell Biology, Volume 132, 1996  176 Figure 8. Confocal immunofluorescence microscopy of PC12 cells undifferentiated (a and b) or differentiated with NGF (c, d, e, and f) 
stained with anti-VAMP-1 (a), with anti-VAMP-2 (b), or double stained with anti-VAMP-1 and synaptophysin (c and e, respectively) 
or anti-VAMP-2 and synaptophysin (d and f, respectively). Bars: (a and b)5 p~m; (c, d, e, and f) 10 ~m. 
SNAP-25  that  constitutes  the  core-nucleus  of  the  neu- 
roexocytosis complex  (Hayashi  et  al.,  1994;  Chapman  et 
al., 1994). 
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